Publications by authors named "P Mourlanette"

Claim this Profile
C
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study.
Florent Huang, Lucas Rémi Khellaf, Guillaume Lefèvre, Alvise Berti, Thomas d'Humières, Pierre Mourlanette

J Allergy Clin Immunol Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial.
Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Lionel Uwer, Pierre Mourlanette

J Thorac Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.
J-L Pujol, A Lavole, E Quoix, O Molinier, P-J Souquet, P Mourlanette

Ann Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial.
Michaël Duruisseaux, Laurence Baudrin, Elisabeth Quoix, Marie Wislez, Denis Moro-Sibilot, Pierre Mourlanette

J Thorac Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.
Jacques Cadranel, Elisabeth Quoix, Laurence Baudrin, Pierre Mourlanette, Denis Moro-Sibilot

J Thorac Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis